Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Aarti Pharmalabs Ltd.
Swot
Aarti Pharmalabs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Aarti Pharmalabs Ltd. has 15 Strengths, 4 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(15)
Weakness
(4)
Opportunity
(2)
Threats
(1)
Others
(1)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Stock passes majority of CANSLIM Investment criteria
Mid-range Performer (DVM)
Company with high TTM EPS Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Company with Low Debt
Annual Net Profits improving for last 2 years
Company with Zero Promoter Pledge
Negative to Positive growth in Sales and Profit with Strong Price momentum
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Promoter decreasing their shareholding
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Decline in Quarterly Net Profit (YoY)
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV
Buys by Superstar Investors
FII / FPI or Institutions increasing their shareholding
MFs decreased their shareholding last quarter
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
